VECTRON Trademark

Trademark Overview


On Monday, August 1, 2022, a trademark application was filed for VECTRON with the United States Patent and Trademark Office. The USPTO has given the VECTRON trademark a serial number of 79352300. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by VectorY B.V.. The VECTRON trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Viral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparat...

Medical treatment by gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics

Scientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics
vectron

General Information


Serial Number79352300
Word MarkVECTRON
Filing DateMonday, August 1, 2022
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7376435
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 20, 2024

Trademark Statements


Goods and ServicesViral systems comprised of viral vectors combined with antibodies; gene therapy systems comprised of viral vectors combined with antibodies; nucleic acid delivery systems being therapeutic agents for delivery to human tissue namely viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for the treatment neuro degenerative and neuromuscular disorders being autoimmune diseases; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases; clinical medical reagents for use in nucleic acid-based therapy, cell therapy, pharmaceutical preparations, prophylaxis products preparations and other pharmaceutical products preparations and other pharmaceutical products preparations for use in nucleic acid-based therapy, gene therapy for the treatment of neuro degenerative and neuromuscular disorders being autoimmune diseases
Goods and ServicesMedical treatment by gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
Goods and ServicesScientific and medical research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Scientific and medical research and product development in the field of pharmaceutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 14, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 14, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVectorY B.V.
Party Type30 - Original Registrant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameVectorY B.V.
Party Type20 - Owner at Publication
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Party NameVectorY B.V.
Party Type10 - Original Applicant
Legal Entity Type26 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Thursday, October 13, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2022APPLICATION FILING RECEIPT MAILED
Tuesday, April 11, 2023NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 18, 2023ASSIGNED TO EXAMINER
Friday, May 19, 2023NON-FINAL ACTION WRITTEN
Saturday, May 20, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 27, 2023REFUSAL PROCESSED BY MPU
Tuesday, June 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, July 22, 2023REFUSAL PROCESSED BY IB
Thursday, December 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 8, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2023EXAMINERS AMENDMENT -WRITTEN
Tuesday, December 12, 2023EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, December 12, 2023EXAMINER'S AMENDMENT ENTERED
Monday, December 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 2, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, January 2, 2024WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, January 31, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 7, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 7, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, February 20, 2024PUBLISHED FOR OPPOSITION
Monday, February 26, 2024NOTIFICATION PROCESSED BY IB
Monday, March 4, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 1, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Wednesday, March 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, August 7, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, October 31, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 31, 2024FINAL DISPOSITION PROCESSED